Clinical Trial Update: Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating primary chemotherapy regimens (docetaxel-capecitabine and doxorubicin-cyclophosphamide) in breast cancer has completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• Taxotere (docetaxel)
• Xeloda (capecitabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer, Breast Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2012-08-27